NXTC
NextCure, Inc. - Common Stock (NXTC)
$96
About NextCure, Inc. - Common Stock (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Details
Daily high
$6.30
Daily low
$5.96
Price at open
$6.09
52 Week High
$15.74
52 Week Low
$1.55
Market cap
28.0M
Dividend yield
-
Volume
18,850
Avg. volume
99,296
P/E ratio
-.58
NextCure, Inc. - Common Stock News
Details
Daily high
$6.30
Daily low
$5.96
Price at open
$6.09
52 Week High
$15.74
52 Week Low
$1.55
Market cap
28.0M
Dividend yield
-
Volume
18,850
Avg. volume
99,296
P/E ratio
-.58